Bio-logic Announces New Hearing Agreement with Premier Purchasing Partners, L.P.
08 9월 2005 - 8:00PM
Business Wire
Bio-logic Systems Corp. (Nasdaq:BLSC), a designer and marketer of
computerized medical electrodiagnostic equipment and disposables,
today announced the signing of a new agreement with Premier
Purchasing Partners, L.P., the group purchasing division of
Premier, Inc., one of the largest healthcare alliances in the U.S.
Under this multisource agreement, which is effective from September
1, 2005 through April 30, 2007, Bio-logic will offer its full range
of auditory products and related accessories to Premier's
affiliated hospital and healthcare systems. "With a history of
innovation, and a goal of improving health and the quality of life
through providing cost-effective products and services, we have
shared values with Premier," Roderick G. Johnson, president and
chief operating officer of Bio-logic, commented. "Bio-logic has
become a leader in the hearing field by developing a full range of
products to both screen for and diagnose hearing problems, and by
partnering with other leaders in the hearing community to bring
state-of-the-art technologies to the marketplace. This agreement
enables Premier hospitals and health care providers to continue to
purchase our market leading products at very attractive prices, and
to bring high quality care at a competitive cost to the patients
they serve. "Bio-logic offers a fully integrated suite of products
and services for the hearing market. Launched only about a year
ago, our HALO Ear Muffin(R) has gained strong acceptance among
hearing professionals for its ease of use and baby-friendly
features. The HALO is a disposable over-the-ear acoustic coupler
that can be used with our ABaer(R) and Navigator(R) Pro
M-A-S-T-E-R(R) systems, and also has demonstrated acoustic
equivalence for use with competitive products. The ABaer is our
leading infant hearing screening system, which allows babies to be
screened efficiently through the use of Auditory Brainstem Response
and/or Otoacoustic Emissions technology. The Navigator Pro is our
flexible diagnostic platform system that can expand as we add new
technologies. It can be used with software such as Stacked ABR(TM)
to detect auditory nervous system abnormality, CHAMP(TM) for
diagnosing cochlear hydrops and M-A-S-T-E-R for diagnosis of
hearing loss. Together with our educational seminars and customer
service programs, no other company provides a more complete range
of products and services for the hearing professional. "This new
agreement with Premier, one of the leading healthcare alliances in
the nation, confirms the acceptance of Bio-logic's product offering
by their substantial user base and affords us the opportunity to
further penetrate the hearing market. We are gratified that Premier
has chosen Bio-logic as one of only two suppliers on this
significant contract," Johnson concluded. About Bio-logic Bio-logic
Systems Corp., headquartered in Mundelein, IL, designs, develops,
assembles and markets computer-based electrodiagnostic systems and
related disposables for use by hospitals, clinics, school
districts, universities and physicians. The systems conduct tests
that are typically used by medical practitioners to aid in the
diagnosis of certain neurological disorders, brain disorders and
tumors and sensory disorders, including audiological and hearing
screening and diagnosis. About Premier, Inc. Premier, Inc., is a
healthcare alliance entirely owned by more than 200 of the nation's
leading not-for-profit hospital and healthcare systems. These
systems operate or are affiliated with nearly 1,500 hospital
facilities and thousands of other healthcare sites. Premier
provides an array of resources, including group purchasing for more
than $25 billion annually in supplies and equipment. Premier also
offers supply chain, clinical and operational performance
improvement products and services, and insurance programs. A leader
in helping hospitals improve clinical outcomes while lowering
costs, Premier maintains the nation's largest database for hospital
quality benchmarking with more than three billion patient charge
records and 2.8 terabytes of data. Premier has offices in
Charlotte, NC; Chicago, IL; San Diego, CA; and Washington, D.C.
Cautionary Note Regarding Forward-Looking Statements This release
contains forward-looking statements (as such term is defined in
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934). Management has attempted to
identify these forward-looking statements by using words such as
"may," "will," "expects," "anticipates," "believes," "intends,"
"estimates," "could," "should," "projects" or similar expressions,
but these words are not the exclusive way of identifying these
statements. These forward-looking statements are based on
information currently available to management and are subject to a
number of risks, uncertainties and other factors that could cause
Bio-logic's actual results, performance, prospects or opportunities
to differ materially from those expressed in, or implied by, these
forward-looking statements. These risks, uncertainties and other
factors include general economic and business conditions, turnover
in Bio-logic's sales force, lack of acceptance of new technology by
clinicians and other health care professionals, the results of
research and development efforts, technological changes,
competition, potential changes in regulation by the FDA, costs
relating to manufacturing of products, the timing of customer
orders, the ability of certain suppliers to meet requirements,
Bio-logic's performance under this agreement and other factors
detailed from time to time in Bio-logic's filings with the
Securities and Exchange Commission. You should not place undue
reliance on any forward-looking statements. Except as expressly
required by the federal securities laws, Bio-logic undertakes no
obligation to publicly update or revise any forward-looking
statements, whether as a result of new information, future events,
changed circumstances or any other reason after the date of this
release.
Bio Logic (NASDAQ:BLSC)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Bio Logic (NASDAQ:BLSC)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024